Literature DB >> 22949699

Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs.

Drew J Adams1, Mingji Dai, Giovanni Pellegrino, Bridget K Wagner, Andrew M Stern, Alykhan F Shamji, Stuart L Schreiber.   

Abstract

Piperlongumine is a naturally occurring small molecule recently identified to be toxic selectively to cancer cells in vitro and in vivo. This compound was found to elevate cellular levels of reactive oxygen species (ROS) selectively in cancer cell lines. The synthesis of 80 piperlongumine analogs has revealed structural modifications that retain, enhance, and ablate key piperlongumine-associated effects on cells, including elevation of ROS, cancer cell death, and selectivity for cancer cells over nontransformed cell types. Structure/activity relationships suggest that the electrophilicity of the C2-C3 olefin is critical for the observed effects on cells. Furthermore, we show that analogs lacking a reactive C7-C8 olefin can elevate ROS to levels observed with piperlongumine but show markedly reduced cell death, suggesting that ROS-independent mechanisms, including cellular cross-linking events, may also contribute to piperlongumine's induction of apoptosis. In particular, we have identified irreversible protein glutathionylation as a process associated with cellular toxicity. We propose a mechanism of action for piperlongumine that may be relevant to other small molecules having two sites of reactivity, one with greater and the other with lesser electrophilicity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22949699      PMCID: PMC3458345          DOI: 10.1073/pnas.1212802109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

Review 1.  Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress.

Authors:  P Klatt; S Lamas
Journal:  Eur J Biochem       Date:  2000-08

2.  Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells.

Authors:  Sonam Dolma; Stephen L Lessnick; William C Hahn; Brent R Stockwell
Journal:  Cancer Cell       Date:  2003-03       Impact factor: 31.743

3.  Enhanced toxicity of the protein cross-linkers divinyl sulfone and diethyl acetylenedicarboxylate in comparison to related monofunctional electrophiles.

Authors:  James D West; Chelsea E Stamm; Haley A Brown; Samantha L Justice; Kevin A Morano
Journal:  Chem Res Toxicol       Date:  2011-08-08       Impact factor: 3.739

4.  Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site.

Authors:  Thierry Rabilloud; Manfred Heller; Francoise Gasnier; Sylvie Luche; Catherine Rey; Ruedi Aebersold; Mohamed Benahmed; Pierre Louisot; Joel Lunardi
Journal:  J Biol Chem       Date:  2002-03-19       Impact factor: 5.157

5.  Creation of human tumour cells with defined genetic elements.

Authors:  W C Hahn; C M Counter; A S Lundberg; R L Beijersbergen; M W Brooks; R A Weinberg
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

6.  Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress.

Authors:  Albena T Dinkova-Kostova; Karen T Liby; Katherine K Stephenson; W David Holtzclaw; Xiangqun Gao; Nanjoo Suh; Charlotte Williams; Renee Risingsong; Tadashi Honda; Gordon W Gribble; Michael B Sporn; Paul Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

7.  Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species.

Authors:  A C Lee; B E Fenster; H Ito; K Takeda; N S Bae; T Hirai; Z X Yu; V J Ferrans; B H Howard; T Finkel
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

8.  Production of large amounts of hydrogen peroxide by human tumor cells.

Authors:  T P Szatrowski; C F Nathan
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

9.  Protein S-thiolation targets glycolysis and protein synthesis in response to oxidative stress in the yeast Saccharomyces cerevisiae.

Authors:  Daniel Shenton; Chris M Grant
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

10.  Synthesis and structure-activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2).

Authors:  Allan Wissner; Elsebe Overbeek; Marvin F Reich; M Brawner Floyd; Bernard D Johnson; Nellie Mamuya; Edward C Rosfjord; Carolyn Discafani; Rachel Davis; Xiaoqing Shi; Sridhar K Rabindran; Brian C Gruber; Fei Ye; William A Hallett; Ramaswamy Nilakantan; Ru Shen; Yu-Fen Wang; Lee M Greenberger; Hwei-Ru Tsou
Journal:  J Med Chem       Date:  2003-01-02       Impact factor: 7.446

View more
  68 in total

1.  Using Sensors and Generators of H2O2 to Elucidate the Toxicity Mechanism of Piperlongumine and Phenethyl Isothiocyanate.

Authors:  Beijing K Huang; Troy F Langford; Hadley D Sikes
Journal:  Antioxid Redox Signal       Date:  2016-06-01       Impact factor: 8.401

2.  Piperlongumine induces cell death through ROS-mediated CHOP activation and potentiates TRAIL-induced cell death in breast cancer cells.

Authors:  Hyeon-Ok Jin; Yun-Han Lee; Jin-Ah Park; Ha-Na Lee; Jin-Hee Kim; Ji-Young Kim; BoRa Kim; Sung-Eun Hong; Hyun-Ah Kim; Eun-Kyu Kim; Woo Chul Noh; Jong-Il Kim; Yoon Hwan Chang; Seok-Il Hong; Young-Jun Hong; In-Chul Park; Jin Kyung Lee
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-15       Impact factor: 4.553

3.  Design and synthesis of cenocladamide analogues and their evaluation against breast cancer cell lines.

Authors:  Carla C F Santos; Luciana S Paradela; Luiz F T Novaes; Sandra M G Dias; Julio C Pastre
Journal:  Medchemcomm       Date:  2016-11-25       Impact factor: 3.597

4.  Bifunctional electrophiles cross-link thioredoxins with redox relay partners in cells.

Authors:  Matthew R Naticchia; Haley A Brown; Francisco J Garcia; Andrew M Lamade; Samantha L Justice; Rachelle P Herrin; Kevin A Morano; James D West
Journal:  Chem Res Toxicol       Date:  2013-03-04       Impact factor: 3.739

5.  Structural and Biochemical Analyses Reveal the Mechanism of Glutathione S-Transferase Pi 1 Inhibition by the Anti-cancer Compound Piperlongumine.

Authors:  Wayne Harshbarger; Sudershan Gondi; Scott B Ficarro; John Hunter; Durga Udayakumar; Deepak Gurbani; William D Singer; Yan Liu; Lianbo Li; Jarrod A Marto; Kenneth D Westover
Journal:  J Biol Chem       Date:  2016-11-21       Impact factor: 5.157

Review 6.  Chalcone: A Privileged Structure in Medicinal Chemistry.

Authors:  Chunlin Zhuang; Wen Zhang; Chunquan Sheng; Wannian Zhang; Chengguo Xing; Zhenyuan Miao
Journal:  Chem Rev       Date:  2017-05-10       Impact factor: 60.622

Review 7.  Targeting tumour-supportive cellular machineries in anticancer drug development.

Authors:  Matthias Dobbelstein; Ute Moll
Journal:  Nat Rev Drug Discov       Date:  2014-03       Impact factor: 84.694

8.  Piperlongumine inhibits the proliferation, migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis.

Authors:  Siqi Xu; Youjun Xiao; Shan Zeng; Yaoyao Zou; Qian Qiu; Mingcheng Huang; Zhongping Zhan; Liuqin Liang; Xiuyan Yang; Hanshi Xu
Journal:  Inflamm Res       Date:  2017-11-08       Impact factor: 4.575

9.  Targeting cancer cells with the natural compound obtusaquinone.

Authors:  Christian E Badr; Stephanie Van Hoppe; Hawasatu Dumbuya; Lee-Ann Tjon-Kon-Fat; Bakhos A Tannous
Journal:  J Natl Cancer Inst       Date:  2013-03-11       Impact factor: 13.506

10.  Synthesis and Antileukemic Activities of Piperlongumine and HDAC Inhibitor Hybrids against Acute Myeloid Leukemia Cells.

Authors:  Yi Liao; Xiaojia Niu; Bailing Chen; Holly Edwards; Liping Xu; Chengzhi Xie; Hai Lin; Lisa Polin; Jeffrey W Taub; Yubin Ge; Zhihui Qin
Journal:  J Med Chem       Date:  2016-08-24       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.